Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction.
暂无分享,去创建一个
S. Miyazaki | Y. Goto | S. Ohshima | H. Nonogi | A. Itoh | S. Daikoku | K. Haze | Y. Kobayashi
[1] M. Hori,et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. , 1997, American heart journal.
[2] M. Fujita,et al. Effective and safe dose of intracoronary nicorandil in man. , 1995, Japanese circulation journal.
[3] R. Califf,et al. Intravenous Fluosol in the Treatment of Acute Myocardial Infarction: Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial , 1994, Circulation.
[4] E. Topol,et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. , 1994, Circulation.
[5] G. Gross,et al. Glibenclamide Antagonizes Adenosine A, Receptor‐Mediated Cardioprotection in Stunned Canine Myocardium , 1993, Circulation.
[6] R. Kloner. Does reperfusion injury exist in humans? , 1993, Journal of the American College of Cardiology.
[7] M. Hori,et al. Staged Reperfusion Attenuates Myocardial Stunning in Dogs: Role of Transient Acidosis During Early Reperfusion , 1991, Circulation.
[8] M. Verani,et al. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. , 1991, Journal of the American College of Cardiology.
[9] E. Topol,et al. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. , 1991, Journal of the American College of Cardiology.
[10] R. Virmani,et al. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. , 1991, Circulation.
[11] L. Opie. Reperfusion injury and its pharmacologic modification. , 1989, Circulation.
[12] K. Lee,et al. Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. , 1989, Journal of the American College of Cardiology.
[13] R. Kempsford,et al. Assessment of the antiarrhythmic activity of nicorandil during myocardial ischemia and reperfusion. , 1989, European journal of pharmacology.
[14] R. Virmani,et al. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation. , 1989, Circulation.
[15] H. Hayakawa,et al. Reduction of Size of Myocardial Infarction with Nicorandil, a New Antianginal Drug, After Coronary Artery Occlusion in Dogs , 1988, Journal of cardiovascular pharmacology.
[16] M. Weisfeldt,et al. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. , 1988, The Journal of clinical investigation.
[17] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[18] F. Sheehan,et al. Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function. , 1988, Circulation.
[19] K. Mullane,et al. Does captopril attenuate reperfusion‐induced myocardial dysfunction by scavenging free radicals? , 1988, Circulation.
[20] G. Gross,et al. Beneficial Effects of Iloprost in the Stunned Canine Myocardium , 1988, Circulation research.
[21] G. Gross,et al. Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate. , 1987, Circulation.
[22] F H Sheehan,et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.
[23] N. Taira. Similarity and Dissimilarity in the Mode and Mechanism of Action Between Nicorandil and Classical Nitrates: An Overview , 1987, Journal of cardiovascular pharmacology.
[24] D. Warltier,et al. Comparative Effects of Nicorandil, Nitroglycerin, Nicotinic Acid, and SG‐86 on the Metabolic Status and Functional Recovery of the Ischemic‐Reperfused Myocardium , 1987, Journal of cardiovascular pharmacology.
[25] T. Hakuta,et al. Effects of Nicorandil on Coronary Hemodynamics in Ischemic Heart Disease: Comparison with Nitroglycerin, Nifedipine, and Propranolol , 1987, Journal of cardiovascular pharmacology.
[26] R. Virmani,et al. Determinants of left ventricular aneurysm formation after anterior myocardial infarction: a clinical and angiographic study. , 1986, Journal of the American College of Cardiology.
[27] P. Serruys,et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. , 1986, Journal of the American College of Cardiology.
[28] G. Gross,et al. Improved Recovery of Myocardial Segment Function Following a Short Coronary Occlusion in Dogs by Nicorandil, a Potential New Antianginal Agent, and Nifedipine , 1985, Journal of cardiovascular pharmacology.
[29] G. Gross,et al. Comparative Effects of a New Nicotinamide Nitrate Derivative, Nicorandil (SG 75), with Nifedipine and Nitroglycerin on True Collateral Blood Flow Following an Acute Coronary Occlusion in Dogs , 1984, Journal of cardiovascular pharmacology.
[30] D. Warltier,et al. Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium , 1984, Journal of cardiovascular pharmacology.
[31] S. Holzmann. Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG‐75) , 1983, Journal of cardiovascular pharmacology.
[32] S. Imai,et al. Effects of 2-nicotinamidoethyl nitrate on the cardiovascular system. , 1979, Japanese heart journal.
[33] R. Seabra-Gomes,et al. The assessment of regional abnormalities of the left ventricle by angiography. , 1977, European journal of cardiology.
[34] E. Veys,et al. Letter: HL-A and infective sacroileitis. , 1974, Lancet.